Back

Medscape, LLC

  • Carcinoma, Non-Small-Cell Lung

World Stage Insights: Global Advances in Targeted NSCLC Therapies

The goal of this activity is for learners to be better able to stay apprised of the rapidly evolving advances in targeted therapies for NSCLC and their applicability to clinical practice across practice settings.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Sep 30, 2026
  • Last day to claim credit
    Oct 1, 2027 12 months left